Arkolith/Insider Trading/PTHS/Form 4

Greenleaf Peter

DirectorPelthos Therapeutics Inc. (PTHS) · full profile →Form 4 · filed Jul 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2025Grant(A)78K——78K
Jul 2, 2025Grant(A)25K——25K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001753926-25-001108) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML